Linda McAllister and Michael Royals of PharmaJet, Inc. in the U.S. will research the mechanisms that make intradermal vaccine delivery more effective than intramuscular vaccines. Understanding how immunizations via the skin work and why reduced doses are needed in this method can enable more cost effective approaches to polio eradication and other global public health problems.